Abstract: Objective: To analysis the clinical features of the pancreatic metastasis of SCLC(Small Cell Lung Cancer) and to study its treatments to improve prognosis. Methods: Retrospective analysis was conducted in 14 patients with pancreatic metastasis of SCLC. Results: Of all the 14 patients with pancreatic metastasis of SCLC, the median age was 45.0. There was a 0.63% incidence of pancreatic metastasis of SCLC in all the patients of SCLC in the same period. Of the 12 died patients, the median survival time from the development of pancreatic metastasis to death was 11 months. (range 1.5 -44 months). Conclusions: Although the incidence of pancreatic metastasis from SCLC is rare, the early definite diagnosis and active treatment is needed.